Heather Macdonald

Dr. Heather Macdonald


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2006 in The American Journal of Surgery
Verified
Journal Article
Closed access
HMHeather Macdonald
Heather Macdonald
MSMelvin J. Silverstein
Melvin J. Silverstein
LLLaura A. Lee
Laura A. Lee
WYWei Ye
Wei Ye
PSPremal Sanghavi
Premal Sanghavi
MLMichael Lagios
Michael Lagios

14 January 2020 in The Breast Journal
Verified
Journal Article
Closed access
HMHeather Macdonald
Heather Macdonald

1 July 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
GUGary A. Ulaner
Gary A. Ulaner
MSMel Silverstein
Mel Silverstein
CNChaitali Nangia
Chaitali Nangia
MTMerry Tetef
Merry Tetef
LVLouis Vandermolen
Louis Vandermolen
AMAudrey Mauguen
Audrey Mauguen
Importance: There are insufficient data comparing 16α-18F-fluoro-17β-estradiol (FES) positron emission tomography (PET) computed tomography (CT) with standard-of-care imaging (SOC) for staging locally advanced breast cancer (LABC) or evaluating suspected recurrence.Objective: To determine the detection rate of FES PET/CT and SOC for distant metastases in patients with estrogen receptor (ER)-positive LABC and recurrences in patients with ER-positive BC and suspected recurrence.Design, Setting, and Participants: This diagnostic study was conducted as a single-center phase 2 trial, from January 2021 to September 2023. The study design provided 80% power to find a 20% detection rate difference. Participants included patients with ER-positive LABC (cohort 1) or suspected recurrence (cohort 2). Data were analyzed from September 2023 to February 2024.Exposure: Participants underwent both SOC imaging and experimental FES PET/CT. When there were suspicious lesions on imaging, 1 was biopsied for histopathological reference standard to confirm presence (true positive) or absence (false positive) of malignant neoplasm.Main Outcomes and Measures: The outcome of interest was the detection rate of FES PET CT vs SOC for distant metastases and recurrences.Results: A total of 124 patients were accrued, with 62 in cohort 1 (median [IQR] age, 52 [32-84] years) and 62 in cohort 2 (median [IQR] age, 66 [30-93] years). In cohort 1, of 14 true-positive findings, SOC imaging detected 12 and FES detected 11 (P > .99). In cohort 2, of 23 true-positive findings, SOC detected 16 and FES detected 18 (P = .77). In 30 patients with lobular histology, of 11 true-positive findings, SOC detected 5 and FES detected 9 (P = .29). There were 6 false-positive findings on SOC and 1 false-positive finding on FES PET/CT (P = .13).Conclusions and Relevance: In this diagnostic study with pathological findings as the reference standard, no difference was found between FES PET/CT and current SOC imaging for detecting distant metastases in patients with ER-positive LABC or recurrences in patients with ER-positive tumors and suspected recurrence. FES PET/CT could be considered for both clinical indications, which are not part of current Appropriate Use Criteria for FES PET. The findings regarding FES PET/CT in patients with lobular tumors, and for lower false positives than current SOC imaging, warrant further investigation.

1 May 2006 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
CAC.A. Amezcua
C.A. Amezcua
HMHeather Macdonald
Heather Macdonald
CLC.A. Lum
C.A. Lum
WYW. Yi
W. Yi
LML.I. Muderspach
L.I. Muderspach
JFJ.C. Felix
J.C. Felix

16 May 2020 in The Breast Journal
Verified
Journal Article
Closed access
PDF file
BDBrian P. Dickinson
Brian P. Dickinson
DHDennis Holmes
Dennis Holmes
NVNikkie Vu‐Huynh
Nikkie Vu‐Huynh
MVMonica B. Vu
Monica B. Vu
LSLincoln Snyder
Lincoln Snyder
PAPeter H. Ashjian
Peter H. Ashjian
Mastectomy breast reconstruction with autologous tissue is challenging. Oncologic and aesthetic goals face previous surgical scars, radiation, chemotherapy, or other comorbidities. We describe a simple approach for autologous mastectomy reconstruction so that breast and plastic and reconstructive surgeons can maximize aesthetic outcomes and minimize wound complications. A retrospective chart review was done on patients who underwent mastectomy and autologous reconstruction. The surgical flight plans were reviewed to delineate an approach, and pre‐ and postoperative photographs were examined to create a step‐by‐step process. The most encountered mastectomy and autologous flap reconstruction scenarios were categorized to create a step‐by‐step process. Successful autologous mastectomy reconstruction to optimize aesthetic outcome and minimize complications requires team communication. Creation of a surgical flight plan using information from the physical examination, MRI and adjunctive imaging, and preoperative photographs is imperative. Thoughtful incision choice and exposure approach are paramount.